Ultravate Cream 0.05% is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.Treatment beyond two consecutive weeks is not recommended,and the total dosage should not exceed 50g/week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.Use in children under 12 years of age is not recommended.

As with other highly active corticosteroids,therapy should be discontinued when control has been achieved.If no improvement is seen within 2 weeks,reassessment of the diagnosis may be necessary.

Apply a thin layer of Ultravate Cream to the affected skin once or twice daily,as directed by your physician,and rub in gently and completely.

Ultravate (halobetasol propionate cream) Cream is a super-high potency topical corticosteroid; therefore,treatment should be limited to two weeks,and amounts greater than 50 g/wk should not be used.As with other corticosteroids,therapy should be discontinued when control is achieved.If no improvement is seen within 2 weeks,reassessment of diagnosis may be necessary.

Ultravate Cream should not be used with occlusive dressings.

Ultravate® (halobetasol propionate cream) Cream,0.05% is supplied in the following tube sizes:

15 g (NDC 0072-1400-15)
50 g (NDC 0072-1400-50)

Storage

Store between 15°C and 30°C (59°F and 86°F).

Bristol-Myers Squibb Company, Princeton,NJ 08543, USA. FDA Rev date: 9/17/2004

Bookmark this page: